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Greenford, Middlesex, United Kingdom; 8 mg administered
by means of an intravenous bolus). Two intensivists who were
trained for 2 weeks by the team preparing the scoring system
evaluated and scored each patient without knowing whether
they received the drug. Patients were re-evaluated 10 minutes
later, and a postdrug score was assigned. Evaluation before
and after treatment was not done by the same intensivist to
reduce the risk of bias.
Results.  The Wilcoxon signed-rank test was used for sta-
tistical evaluation, and the fall in delirium score after
ondansetron treatment was found to be statistically significant
(P = .001, Table II). One patient who continued to have a
score of 4 despite treatment had to be fully sedated.
Discussion. Large numbers of vasoactive substances,
including histamine and serotonin, are produced or affected
by CPB and cardiac operations.3 The lungs, brain, and, to a
lesser extent, the kidneys have long been considered the pri-
mary targets of inflammatory mediators released during CPB.
Recent studies indicate that vasoactive compounds, such as
histamine and 5HT, are released by platelets during platelet
aggregation.3 The lung plays an important function in the
uptake and release of vasoactive substances, and the lung is
known to inactivate circulating serotonin and bradykinin and
participates in the uptake of norepinephrine. It has been
hypothesized that systemic hypertension after CPB is caused
by depressed clearance of neurohumoral substances by the
damaged lung after CPB. Data suggest that the diminution in
the lung’s ability to remove substances like norepinephrine
and serotonin from the circulation is directly related to the
duration of CPB. During CPB, many factors, such as high-
dose heparin, the shear effect on thrombocytes causing mast
cells to release serotonin, and inactivation of metabolic lung
function, can be factors contributing to the much higher inci-
dence of postoperative delirium after cardiac operations in
comparison with other operations.3,4 A phenomenon referred
to as the serotonin syndrome has been described after the use
Delirium remains the most common psychiatric disorder
seen early after cardiac operations, with an incidence of 13%
to 70%. It is characterized by reduced levels of consciousness,
perceptual disturbances (eg, hallucinations), a disturbance in
the sleep-wake cycle, and disturbed psychomotor activity.1,2
The serotonergic system, which has been implicated in the
development of anxiety disorders, is affected by cardiopul-
monary bypass (CPB) along with many other systems and
may be one of the contributing factors causing delirium. The
purpose of this study was to determine whether ondansetron,
a 5HT3 receptor antagonist, could be effective in treating this
disorder.
Methods.  After the approval of the ethical commission and
institutional review board, informed consent was obtained
from family members of 35 patients in whom delirium devel-
oped in the intensive care unit after coronary artery surgery.
Patients with previous psychiatric disorders were excluded.
Every effort was made to correct any metabolic abnormality,
such as hypoxia, low cardiac output, and electrolyte distur-
bance before evaluation, that could cause this disorder. Before
the operation, patients were premedicated with midazolam
(0.07-0.1 mg/kg administered intramuscularly). Anesthesia
was induced with fentanyl and midazolam, and all patients
received standard doses of morphine and midazolam perfu-
sion for basal sedation and analgesia in the early postoperative
period. Patient characteristics are shown in Table I. After
going through previous anxiety and agitation scores, a scoring
system was developed with the collaboration of the depart-
ments of neurology, psychiatry, and anesthesiology, and pre-
treatment scoring was done. Afterward, all patients received a
single dose of ondansetron (Zofran; Glaxo Wellcome,
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Table I. Patient characteristics
Age (mean) 51 ± 19
Male 23
Female 12
Onset of delirium after surgery (h) 35 ± 7
The time of onset of delirium symptoms was mostly 1.5 days after surgery in
the intensive care unit.
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of serotomimetic agents alone or in combination with
monoamine oxidase inhibitors (MAOIs). Main features
include change in mental status and behavior (agitation, con-
fusion, disorientation, and restlessness) and some motor sys-
tem dysfunctions. Several patients given a diagnosis of sero-
tonin syndrome had minor symptoms, including agitation,
poor concentration, and restlessness.5 Many of our patients,
especially those with scores of 3 and 4, had symptoms resem-
bling those of a milder form of the serotonin syndrome.
Serotonin is implicated in the cause of anxiety panic disor-
ders and social phobia, and preliminary findings from two
multicenter studies suggested that patients with panic disor-
der and social phobia benefit from long-term oral treatment
with ondansetron. Ondansetron has been used in schizophre-
nia for its antipsychotic effect and in the treatment of social
phobias for its anxiolitic effects.6,7 Data emerging from these
studies suggest that ondansetron may be helpful in treating
anxiety and panic disorders without major side effects. Our
findings were similar. The effect of the drug varied from
patient to patient, but it lasted between 1 and 3 hours.
Although headache and constipation have been described
with the long-term use of the drug,6 this was not our experi-
ence. We realize that there is no single best treatment for post-
cardiotomy delirium, but we do suggest the use of
ondansetron because its use was safe, effective, and without
side effects.
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Table II. Mental status of patients with postcardiotomy delirium* before and after ondansetron
Agitation†
State of awareness Nonaggressive
Normal Confusion Verbal§ Psychomotor Aggressive‡
Good cooperation, Good cooperation, Cooperation possible Uncooperative Uncooperative 
slightly mild-moderate but disoriented, disoriented, difficulty disoriented, verbal
disoriented disorientation, difficulty in in remembering, and physical abuse,
restlessness remembering and an  physical movements shouting,
expression of fear, in bed that can self-destructive
noncompliant cause self-damage, and can harm others 
fear and anxiety obnoxious, visual  
hallucinations,
paranoid delusions
Mental 0 1 2 3 4
status scores 
No. of patients 7 (20%) 10 (28.6%) 18 (51.4%)
before ondansetron
No. of patients 28 (80%) 6 (17.1%) 1# (2.9%)
after ondansetron¶
*Delirium—bewildered, restless, confused disoriented reaction associated with fear and hallucination.
†Agitation—anxiety associated with severe motor restlessness, which was evaluated as verbal (score 2) or psychomotor (score 3).
‡Aggressive—forceful, goal-directed action that may be verbal or psychomotor and is the motor counterpart of rage, anger, or hostility.
§Verbal—disturbance in structure of association in speech (irrelevant answer, word salad, neologism).
Psychomotor—restlessness, hyperactivity with some mental symptoms.
¶The fall in mental state score from a preoperative mean score of 3.20 ± 1.01 (n = 35) to a mean score of 0.29 ± 0.75 (n = 35) after ondansetron treatment was found
to be statistically significant (Wilcoxon signed rank test) (P < .001).
#One patient who remained in score 4 despite ondansetron did not respond to neuroleptics and had to be fully sedated.
